Group One Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-14,925
| Closed | -$350K | – | 8066 |
|
|
2025
Q3 | $338K | Sell |
14,925
-1,853
| -11% | -$43.2K | ﹤0.01% | 4111 |
|
|
2025
Q2 | $290K | Sell |
16,778
-13,263
| -44% | -$246K | ﹤0.01% | 3961 |
|
|
2025
Q1 | $657K | Buy |
+30,041
| New | +$830K | ﹤0.01% | 2827 |
|
|
2024
Q4 | – | Sell |
-42,153
| Closed | -$1.27M | – | 7223 |
|
|
2024
Q3 | $1.22M | Buy |
42,153
+7,454
| +21% | +$276K | ﹤0.01% | 2135 |
|
|
2024
Q2 | $1.33M | Buy |
+34,699
| New | +$1.57M | 0.01% | 1764 |
|
|
2024
Q1 | – | Sell |
-253,905
| Closed | -$16.2M | – | 6994 |
|
|
2023
Q4 | $15.2M | Buy |
253,905
+27,221
| +12% | +$1.38M | 0.04% | 462 |
|
|
2023
Q3 | $8.62M | Buy |
226,684
+207,866
| +1,105% | +$9.13M | 0.03% | 600 |
|
|
2023
Q2 | $1.71M | Buy |
18,818
+13,908
| +283% | +$1.2M | 0.01% | 1857 |
|
|
2023
Q1 | $324K | Sell |
4,910
-45,913
| -90% | -$2.65M | ﹤0.01% | 3186 |
|
|
2022
Q4 | $2.63M | Buy |
+50,823
| New | +$2.7M | 0.01% | 1604 |
|
|
2022
Q3 | – | Sell |
-25,823
| Closed | -$1.53M | – | 7505 |
|
|
2022
Q2 | $1.17M | Sell |
25,823
-29,723
| -54% | -$1.36M | ﹤0.01% | 2599 |
|
|
2022
Q1 | $2.82M | Buy |
55,546
+19,525
| +54% | +$862K | ﹤0.01% | 2055 |
|
|
2021
Q4 | $1.7M | Sell |
36,021
-69,731
| -66% | -$2.75M | ﹤0.01% | 2784 |
|
|
2021
Q3 | $3.49M | Buy |
+105,752
| New | +$5.94M | ﹤0.01% | 2071 |
|
|
2020
Q4 | – | Sell |
-1,629
| Closed | -$68.9K | – | 6445 |
|
|
2020
Q3 | $49K | Buy |
+1,629
| New | +$48.7K | ﹤0.01% | 4653 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | -$2.77K | – | 5085 |
|
|
2019
Q3 | $2K | Buy |
+100
| New | +$2.75K | ﹤0.01% | 4901 |
|
Other funds holding APLS
Group One Trading's APLS Position: Q4 2025 in Review
Group One Trading sold out of Apellis Pharmaceuticals (APLS) in Q4 2025, closing a stake of 14,925 shares — an estimated $350K sold.
Group One Trading first reported a position in APLS in Q3 2019 and held it in 16 quarters. The position peaked at $15.2M in Q4 2023. 279 funds tracked by Wall St. Rank hold APLS as of Q4 2025.
- Group One Trading reported no remaining Apellis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 14,925 Apellis Pharmaceuticals shares in Q4 2025, an estimated $350K.
- Group One Trading first reported a position in Apellis Pharmaceuticals in Q3 2019 and held it in 16 quarters.
- Group One Trading's Apellis Pharmaceuticals position peaked at $15.2M in Q4 2023.
- 279 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.